Error loading player: No playable sources found

114076

WATCH NOW: Utilizing HiBiT Targeted Cell Killing Bioassays To Validate Cell Therapy and mAb-Mediated Immunotherapy Potency

Date
June 11, 2024
This product is not available for individual purchase, but it is available as part of the following products:

This technical Seminar will be available to watch on demand 24/7 during the Symposium. Click on this session to access the presentation video. 

NOTE: If prompted to login to view the video, enter your CASSS member credentials. 


Presented by: Promega Corporation 


Related Products

Thumbnail for Plenary Session 8 - Global Regulatory Updates and Panel Discussion & Closing Remarks
Plenary Session 8 - Global Regulatory Updates and Panel Discussion & Closing Remarks
The cell and gene therapy field spans an enormous range of product types and technologies with the potential to provide curative treatments for a wide range of serious diseases…
Thumbnail for Plenary Session 4 - Potency Assays for Gene Edited Products
Plenary Session 4 - Potency Assays for Gene Edited Products
Measurement of the biological activity is crucial for lot release, stability and any comparability exercise of all biological medicinal products…
Thumbnail for Comparability Regulatory Panel & Closing Remarks
Comparability Regulatory Panel & Closing Remarks
Engaging Global Regulators in Discussion on Comparability for Cell-based Medicinal Products: Industry Challenges and a Path Towards Harmonized Solutions